We are live on
!
Find out more
EIM
Essex Investment Management Portfolio holdings
AUM
$632M
1-Year Est. Return
95.36%
This Fund
S&P 500
This Quarter
Est. Return
+31.23%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$550M
AUM Growth
+$70.6M
(+15%)
Cap. Flow
-$37M
Cap. Flow
% of AUM
-6.73%
Top 10 Holdings %
Top 10 Hldgs %
19.32%
Holding
327
New
24
Increased
23
Reduced
152
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mirum Pharmaceuticals
MIRM
|
+$5.02M |
| 2 |
GE Vernova
GEV
|
+$2.92M |
| 3 |
Cohu
COHU
|
+$2.47M |
| 4 |
Mama's Creations
MAMA
|
+$2.39M |
| 5 |
Orion Group Holdings
ORN
|
+$2.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUTX
Nutex Health
NUTX
|
+$7.08M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$6.56M |
| 3 |
Travere Therapeutics
TVTX
|
+$4.56M |
| 4 |
Generac Holdings
GNRC
|
+$3.88M |
| 5 |
Guidewire Software
GWRE
|
+$3.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 30.33% |
| 2 | Technology | 26.01% |
| 3 | Healthcare | 18.4% |
| 4 | Financials | 6.04% |
| 5 | Consumer Staples | 4.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kratos Defense & Security Solutions
KTOS
$12B
| $16.3M | 2.96% |
350,352
-4,315
| -1% | -$156K |
|
2
American Superconductor
AMSC
$1.57B
| $12.7M | 2.31% |
346,042
-26,179
| -7% | -$643K |
|
3
Sterling Infrastructure
STRL
$16.8B
| $12.3M | 2.23% |
53,121
-804
| -1% | -$140K |
|
4
Leonardo DRS
DRS
$12B
| $11.8M | 2.15% |
254,042
-1,817
| -0.7% | -$73K |
|
5
AvePoint
AVPT
$2.75B
| $9.9M | 1.8% |
512,703
-6,926
| -1% | -$120K |
|
6
Microsoft
MSFT
$3.66T
| $9.19M | 1.67% |
18,485
-323
| -2% | -$140K |
|
7
HCI Group
HCI
$2.28B
| $9.13M | 1.66% |
59,981
-17,889
| -23% | -$2.75M |
|
8
Lincoln Educational Services
LINC
$968M
| $8.86M | 1.61% |
384,552
-2,794
| -0.7% | -$56K |
|
9
Tower Semiconductor
TSEM
$29.9B
| $8.47M | 1.54% |
195,296
+22,237
| +13% | +$854K |
|
|
10
GE Vernova
GEV
$277B
| $7.66M | 1.39% |
14,485
+7,010
| +94% | +$2.92M |
|
11
Apple
AAPL
$4.4T
| $7.52M | 1.37% |
36,647
-909
| -2% | -$184K |
|
12
Adaptive Biotechnologies
ADPT
$3.97B
| $7.19M | 1.31% |
617,299
-4,413
| -0.7% | -$40.1K |
|
13
Ligand Pharmaceuticals
LGND
$5.81B
| $6.91M | 1.26% |
60,810
-892
| -1% | -$95.3K |
|
14
Graham Corp
GHM
$1.32B
| $6.88M | 1.25% |
138,974
-883
| -0.6% | -$32.7K |
|
15
Willdan Group
WLDN
$1.29B
| $6.7M | 1.22% |
107,227
-29,863
| -22% | -$1.42M |
|
16
Insmed
INSM
$29B
| $6.68M | 1.21% |
66,345
-455
| -0.7% | -$34.8K |
|
17
Amazon
AMZN
$2.9T
| $6.49M | 1.18% |
29,599
-688
| -2% | -$136K |
|
18
Goldman Sachs
GS
$302B
| $6.48M | 1.18% |
9,149
+57
| +0.6% | +$33K |
|
19
Mirion Technologies
MIR
$3.81B
| $6.46M | 1.17% |
299,816
-2,057
| -0.7% | -$35.5K |
|
20
Ouster
OUST
$3.29B
| $6.07M | 1.1% |
250,172
-16,592
| -6% | -$202K |
|
21
Argan
AGX
$8.11B
| $6.02M | 1.1% |
27,318
-8,892
| -25% | -$1.6M |
|
|
22
Mirum Pharmaceuticals
MIRM
$6.08B
| $5.74M | 1.04% |
+112,731
| New | +$5.02M |
|
23
EverQuote
EVER
$857M
| $5.67M | 1.03% |
234,677
+67,748
| +41% | +$1.61M |
|
24
Ambarella
AMBA
$3.67B
| $5.58M | 1.01% |
84,479
-1,952
| -2% | -$104K |
|
25
NextEra Energy
NEE
$178B
| $5.52M | 1% |
79,535
-26,656
| -25% | -$1.85M |
|
Similar funds
AMM
BI
KCMH
SFM
VIM
AP
TTSTC
WCM
Essex Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, Essex Investment Management held 327 positions worth $550M, up 15% from $479M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Essex Investment Management withdrew a net $37M in Q2 2025, closing 29 positions and reducing 152 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $6.56M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Essex Investment Management opened a new position in Mirum Pharmaceuticals worth $5.74M.
- Essex Investment Management's largest Q2 2025 buy was Mirum Pharmaceuticals: 112,731 shares worth $5.74M.
- Essex Investment Management added most to GE Vernova in Q2 2025, an estimated $2.92M increase.
- Essex Investment Management's biggest Q2 2025 reduction was Nutex Health, cutting an estimated $7.08M.
- Essex Investment Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $6.56M.
- Essex Investment Management's ten largest holdings make up 19% of its $550M portfolio in Q2 2025.
- Essex Investment Management opened 24 new positions and closed 29 in Q2 2025.
- Essex Investment Management's portfolio value rose 15% quarter-over-quarter to $550M.
Based on Essex Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.